GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas.
The Kentucky company has continued its return from bankruptcy by acquiring CBD Capital, a provider of CBD distillate, isolate and water-soluble bulk ingredients as well as white and private label services to the UK, the EU and markets worldwide.
It follows the earlier acquisition of UK-based Taylor Mammon, another major player in the same field.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
